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We have investigated the transcriptional activity of human cytomegalovirus, herpes thymidine kinase, human chorionic gonadotropin a, somatosta- 
tin, immunoglobulin K chain, u crystallin, albumin and interferon-B promoters in the fission yeast Schizosaccharomyces pombe. Among these, the 
human cytomegalovirus, human chorionic gonadotropin a, and somatostatin promoters were found to be very active, approximately 1 1-, 9-, and 
0.9-fold as active as the SV40 early promoter, respectively. The remainder of the promoters studied were weak, having only lO-20$ of the SV40 
promoter activity. Primer extension analysis showed that the strong promoters initiated transcription in S. pornbe at the same sites as in mammalian 
cells, indicating the high similarity between both transcriptional systems. 
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1. INTRODUCTION 
Eukaryotic transcription is regulated by trans-acting 
proteins which specifically interact with c&-acting 
elements residing in the promoter [1,2]. Many pairs of 
cis- and truns-elements have been identified in lower as 
well as higher eukaryotes. The transcriptional regulato- 
ry system seems to be evolutionarily well conserved 
among all eukaryotes. For example, it has been 
reported that Saccharomyces cerevisiae (S. cerevisiae) 
has a TATA binding protein (TF-IID) [3-S], a CCAAT 
box binding protein [6], and an API binding protein 
[7,8] all of which were initially discovered in mam- 
malian cells. 
Like S. cerevisiae, the fission yeast Schizosac- 
charomyces pombe (S. pombe) contains DNA binding 
proteins similar to APl [9], ATF [lo] and TF-IID 
(Hoffman, A. et al., submitted). S. pombe genes, 
similar to mammalian genes, have a TATA element 
25-40 bp upstream of the transcriptional start site [l 11, 
whereas in S. cerevisiae it is 40-120 bp upstream [ 121. 
Fu~hermore, S. pombe correctly splices the SV40 
transcript [13]. Thus, significant similarity exists in 
transcription and RNA processing between S. pombe 
and higher eukaryotes. 
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To evaluate the potential usefulness of S. pombe as 
a model system for investigating mammalian gene ex- 
pression mechanisms, we have examined the activity of 
various m~rn~ian promoters in this microbe. Our 
findings indicate that some promoters are highly active 
in S. pombe, and that transcription from these pro- 
moters initiates at the same sites as in mammalian cells. 
2. MATERIALS AND METHODS 
2.1. Yeast strain and tra~formation 
An S. pombe strain containing the Ura# mutation was transformed 
by the highly efficient alkaline cation method developed by Okazaki 
and Okayama. The detailed procedure will be described elsewhere 
(Okaxaki, K. et al., submitted). 
The ptasmid pAU9 (Okazaki, K. et al., submitted) was partially 
digested with EcoRI, blunt ended and cleaved with PM. A 3.7 kb 
DNA segment containing the autonomously replicating sequences 
(ars) of S. pombe plus the S. cereviriae Ura3 gene was inserted into 
the pcD vector [14] at the TthIII I (blunt ended) and PstI sites. The 
SV40 promoter was replaced by the SV40 polyadenylation site. A 
pofyhnker sequence (5 ’ -SphI-SacI-EcoRV-~g~I-StuI-C~aI-XbaI- 
NdeI-SacII-Kpni-Xho-3’) was introduced between the two BamHI 
sites in the splice junction and the polyadenyiation site of the pcD 
vector, respectively. The resulting plasmid pTR is shown in Fig. 1. 
To construct plasmids containing a promoter linked to the CAT 
gene, pTR was digested with KpnI and the ends blunted (pTR-KpnI). 
The PvuII-UpaI 1.85 kb fragment excised from pSV2CAT [is] was 
inserted into pTR-K@ to create p’I’RSV40. The Hind111 (blunt end- 
ed)-H&r1 fragment of pSV2CAT was ligated with pTR-Kpr11 to con- 
struct a plasmid containing the CAT gene without promoter. The 
same strategy was applied to the human chorionic gonadotropin (Y- 
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subunit (CGa), (Y crystallin, interferon@ and somatostatin pro- 
moters. An EcoRI-Hpal fragment containing the 1.6 kb promoter 
region of CGcv was excised from pcvCAT [16] (obtained from I. 
Boime), a &cl-Hpal fragment containing the 340 bp promoter 
region of murine (Y crystallin was removed from p&336,-CAT [17] 
(obtained from J. Piatigorsky), a Ndel-Hpul fragment containing the 
281 bp promoter region of human interferon-/3 was excised from 
pSV&CAT [18] (obtained from J. Hiscott), and a Bgnl-Hpal frag- 
ment containing the 71 bp promoter region of rat somatostatin was 
released from pD3-CAT [ 191 (obtained from R.H. Goodman). When 
necessary, DNA fragments were blunt ended with E. coli DNA 
polymerase 1. 
To construct plasmids with the human cytomegalovirus (CMV), 
herpes thymidine kinase (TK), murine immunoglobulin x chain (Ig 
x), rat albumin or SV40 late promoters, the SV40 promoter was 
removed from pTRSV40 by BumHI and Hind111 treatment followed 
by blunt ending. The following fragments were introduced into the 
plasmid: the enhancer/promoter region of the major IE gene of CMV 
[20] (-771 to +71); the Pvull-Blgll fragment (250 bp) of the TK 
gene [21]; the enhancer/promoter fragment of Ig x released from 
pKca, [22] by EcoRl and Blgll digestion (1.5 kb); 400 bp of the rat 
albumin promoter obtained by Hincll digestion of SubJB (obtained 
from T.D. Sargent); or the HindIll-Pvull fragment (340 bp) of the 
pSV2CAT [ 151. The orientations of the inserted promoter fragments 
were analyzed by digestion with restriction enzymes followed by 
agarose gel electrophoresis. 
2.3. Extract prepurution and CAT assuy 
Transformants (1.5 x lo6 cells per 10 cm dish) were plated on 
minimal media plates ([23] and Okazaki, K. et al., submitted) and 
cultured at 30°C for 5 days. Transformants were harvested and wash- 
ed twice with water. Cells were resuspended in 1 ml of a solution con- 
taining 1 M sorbitol, 0.1 M EDTA, 14 mM 2-mercaptoethanol, and 
treated with lyticase (Sigma) (0.1 unit per pl of cell suspension) at 
30°C for at least 1 h until the cells became spheroplasts. The 
spheroplasts were harvested by centrifugation and resuspended in 
1.2 ml of a solution containing 92 mM Tris-HCl (pH 7.4) and 
42.5 mM EDTA, then sonicated on ice by a Tekmer Tissumizer 
(power control output strength 70) for 1 min. Cell debris was remov- 
ed by centrifugation at 4°C. The protein concentrations of the ex- 
tracts were measured according to Bradford [24] using the BioRad 
protein assay kit. CAT assays were performed using 0.1 or 0.05 pg of 
extracted protein in 90 ~1 of reaction mixture [15]. 
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Fig. 1. Structure of the pTR vector. The principal elements of the 
pTR vector are (i) a segment of the S. pombe autonomously 
replicating sequences (ars) (solid black area), (ii) S. cerevisiue Uru3 
gene (hatched area), (iii) the segment containing the pBR322 @- 
lactamase gene and the origin of replication (open area), and (iv) two 
fragments containing the SV40 late-region polyadenylation signal 
(poly A) (dot area). The 69 bp polylinker fragment contains unique 
Xhol, Knpl, Sucll, Bg/II, &cl, and Sphl sites. 
2.4. RNA preparation 
Total RNA was prepared from two 10 cm dishes of transformants 
using the glass beads methods [13]. 
2.5. Primer extension 
An oligonucleotide (5 ’ -CAACGGTGGTATATCCAGT-3 ’ ) com- 
plementary to nucleotides +12 to +31 of the CAT coding sequence 
was labeled with T4 polynucleotide kinase and [y-“P]ATP. Sixyg of 
total RNA was annealed to 4 ng of “P-labeled primer (7 x 10’ cpm) 
in 10~1 of a solution containing 10 mM Tris-HCl (pH 8.0), 1 mM 
EDTA, and 0.3 M KC1 at 75°C for 5 min, followed by a 60 min in- 
cubation at 42°C. After the product was ethanol-precipitated, reverse 
transcriptase reactions were performed in 30 pl of a solution contain- 
ing 50 mM Tris-HCI (pH 8.3), 0.33 mM EDTA, 8 mM MgClz, 4 mM 
dithiothreitol, and 0.1 M KC1 at 42°C for 60 min. The products of 
the primer extension reaction were ethanol precipitated and analyzed 
on a 6% acrylamide gel containing 8.3 M urea. 
3. RESULTS 
3.1. Transcriptional activity of mammalian promoters 
in S. pombe 
Promoter fragments long enough to give full 
transcriptional activity in mammalian cells and the 
CAT coding sequence were cloned into the pTR 
plasmid as described in section 2, and introduced into 
S. pombe. Their promoter activities were assayed by 
measuring CAT activities in whole cell extract. We 
tested three general promoters with broad host 
specificity, plus five highly tissue-specific and one in- 
ducible promoter. The general promoters tested were 
those for SV40 T-antigen, human cytomegalovirus 
(CMV), and herpes thymidine kinase (TK). The tissue- 
specific promoters tested were those for human 
chorionic gonadotropin a-subunit (CGm), murine LY 
crystallin, rat albumin, rat somatostatin and murine 
immunoglobulin x chain (Ig x). The inducible pro- 
moter used was the human interferon-b (IFN-fl) pro- 
moter. As shown in Fig. 2, virtually all the promoters 
exhibited transcriptional activity in S. pombe. 
However, the activity varied greatly from promoter to 
promoter. CMV and CGcv were most active (relative ac- 
tivity, lo), SV40 early and somatostatin ext most ac- 
tive (relative activity, 1) and IFN-fi, Ig x, albumin, a 
crystallin, SV40 late and TK least active (relative activi- 
ty, 0.1-0.2). The CAT activity in each extract cor- 
related well with the amount of 1.5 kb CAT mRNA 
determined by Northern analysis (data not shown). The 
Ig x and albumin promoters in reverse orientation 
showed the same activity as the promoterless plasmid. 
The reverse orientation of the CMV promoter was still 
active (12% activity of correct orientation), however as 
shown by primer extension analysis (see below) 
transcriptional initiation seemed to occur from multiple 
sites (data not shown). 
We also studied several mammalian promoters using 
co-transformation. As shown in Fig. 3, the Rous sar- 
coma virus LTR showed an activity in S. pombe similar 
to that of the SV40 early promoter. Other tissue- 
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Fig. 2. Activity of mammalian promoters in S. pombe. The 
expression of CAT coding sequence driven by various mammalian 
promoters in S. pombe was determined by a standard CAT assay. 
100 ng of the extract protein were used in 90 ~1 of reaction mixture 
and incubated for 30 min at 37°C. (A) SV40 early (lane I), human 
cytomegalovirus (lane 2), herpes thymidine kinase (lane 3), 
promoterless plasmid (lane 4), human chorionic gonadotropin (Y (lane 
5), somatostatin (lane 6), immunoglobulin x chain (lane 7), (Y- 
crystallin (lane 8), albumin (lane 9), and interferon@ (lane 10) 
promoters were analyzed. (B) SV40 early (lane 1) and late (lane 2) 
promoters, and promoterless plasmid (lane 3) were analyzed. The 
number below each lane shows the relative CAT activity. The SV40 
early promoter was set at a value of one. 
specific promoters, such as human vasoactive intestinal 
peptide, human interleukin 2 and rat cu-fetoprotein pro- 
moters were very weak in S. pombe. 
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Fig. 3. Activity of mammalian promoters in S. pombe (co- 
transformation). Several mammalian promoters were tested by using 
a co-transformation method (Okazaki, K. et al., submitted). The 
CJru4 strain was transfected with a mixture of PsfI digested pAU9 
(consisting of S. cerevisiae ura3 gene and S. pombe ars; Okazaki, K. 
et al., submitted) (0.4 pg) and 2 pg of various CAT expression 
plasmids. (A) Rous sarcoma virus long terminal repeat (pRSVCAT, 
1321) (lane l), SV40 early (pSVZCAT, [15]) (lane 2) and vasoactive 
intestinal peptide (pVIPCAT5.2, [33]) (lane 4) promoters, as well as 
promoterless plasmid (pSVOCAT, 1151) (lane 3) were analyzed. (B) 
IL-2 (pIL-ZCAT, [34]) (lane 1) and SV40 early (pSVZCAT, [15]) (lane 
2) promoter were tested. (C) cu-Fetoprotein promoter (plasmid 7000, 
[35]) (lane l), promoterless plasmid (pSVOCAT, (151) (lane 2) and 
SV40 early promoter (pSVZCAT, [15]) (lane 3) were examined. CAT 
assays were performed by incubating 15 ng of the extract protein in 
9011 of reaction mixture for 30 min at 37°C. 
3.2. Transcriptional initiation site of mammalian 
promoters in S. pombe 
The transcriptional initiation sites in S. pombe of the 
four most active promoters, CMV, CGa, SV40 early 
and somatostatin, were studied by primer extension 
analysis. In mammalian cells, the transcription initia- 
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1 I+ I CAT 
~.................._____-______~ 
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Fig. 4. Primer extension analysis of the transcription start site of 
mammalian promoters in S. pombe. (A) 6,~g of total RNA from 
yeast cells transformed with the plasmids containing the SV40 early 
(lane l), human cytomegalovirus (CMV; lane 2), human chorionic 
gonadotropin (Y (C&Y; lane 3), or somatostatin (lane 4) promoter 
were analyzed by primer extension using a primer oligonucleotide 
complementary to a sequence within the CAT coding region. (B) The 
transcription initiation sites in S. pombe are summarized. The 
promoter regions are shown as open areas. Arrows indicate the start 
site of transcription in S. pombe. Numbers of base pairs (bp) indicate 
distances from the 5’ end of the primer. 
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tion sites of CMV, CGa, SV40 early and somatostatin 
are 23,24,28 and 26 bp downstream of the TATA box, 
respectively [20,25-271. In S. pombe, we obtained 
fragments of 151 (CMV), 119 (CGLY), 128 (SV40) and 
147 bp (somatostatin) lengths. These were the 
fragments expected if transcription in S. pombe were 
initiated at the same site as in mammalian cells (Fig. 4). 
4. DISCUSSION 
Recent studies have revealed striking similarities in 
transcription mechanisms between high eukaryote and 
yeast cells. For example, a few mammalian promoters 
(e.g. adenovirus early region 3 promoter 1281, SV40 
early promoter [9]) and a plant virus promoter [29] 
have been demonstrated to be active in yeast. 
We report here that the CMV, somatostatin, CGcu, 
TK, Ig X, cu-crystallin, albumin and INF-fi promoters 
are active in S. pombe, though there are substantial 
variations in their activity. Among them, the CMV pro- 
moter was most active, being about 10 times as effec- 
tive as ‘the SV40 early promoter. The activity of the 
latter promoter has been shown to be similar to that of 
the S. pombe alcohol dehydrogenase (adh) promoter 
[9]. Despite their high tissue-specificity exhibited in 
mammalian cells, the CGu, and somatostatin pro- 
moters were also very potent in S. pombe. All other 
promoters were about 5-lo-fold less active than the 
SV40 early promoter. The strengths of these promoters 
in S. pombe, therefore, have no apparent correlation to 
their strengths in mammalian cells, tissue-specificity or 
origin. Moreover, there are no obvious sequence 
similarities between endogenous S. pombe promoters 
[30,31] and the mammalian promoters which were 
highly active in S. pombe. However, comparison of the 
promoter sequences hows that three of the strongest 
promoters (CMV, CGa and somatostatin) contain a 
typical cyclic AMP-responsive element (CRE), while 
the SV40 promoter contains an API binding element 
(ARE). The remaining promoters, which are weak in 
activity, contain neither CRE nor ARE. 
CRE appears to function in S. pombe as does API 
[lo]. Deletion of this element from the CGa promoter 
greatly diminished its activity in S. pombe (R. Toyama, 
unpublished results). If CRE is a major &element 
recognized by the S. pombe transcriptional system, 
transplantation of this element into inactive or weakly 
active promoters should effectively enhance their pro- 
moter activities. Experiments are in progress to ex- 
amine this hypothesis. 
As mentioned above, the CMV and the CGcv pro- 
moter were extremely active in S. pombe. Both pro- 
moters may be useful in constructing expression vectors 
for the production of eukaryotic proteins in S. pombe. 
Since transcriptional control is mediated by specific 
interactions between c&acting DNA sequences and 
their trans-acting factors, transcription is unlikely to 
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occur in the absence of the truns-activator. This may 
explain why many tissue specific or inducible pro- 
moters, such as Ig x, albumin, cu-crystallin, and IFN-,&, 
showed little activity in S. pombe. It might therefore be 
possible to activate these promoters in S. pombe by 
supplying their specific trans-activators. Based on this 
assumption, it might be possible to develop a vector 
system for the cloning of mammalian trans-activator 
proteins using S. pombe as a host. 
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